Evaluating "payback" on biomedical research from papers cited in clinical guidelines: applied bibliometric study
Evaluating "payback" on biomedical research from papers cited in clinical guidelines: applied bibliometric study
复制标题
DOI：
10.1136/bmj.320.7242.1107
复制
发表时间：
2000-04-22
影响因子：
105.7
通讯作者：
Fawcett, G
中科院分区：
文献类型：
--
作者：
Grant, J;Cottrell, R;Fawcett, G
目的建立一种评价研究对卫生保健的影响的方法，并对临床指南中引用的论文进行统计分析。大多数论文是由居住在美国（36%）或英国（25%）的作者发表的--这是预期的两倍半，因为大约10%的生物医学产出是在英国发表的;结论对临床指南的证据基础进行分析，可以跟踪知识从实验室到临床的流动，这种分析提供了一种有用的、与临床相关的方法，用于评估研究成果和研究与发展中的不同战略。
Objectives To develop a methodology for evaluating the impact of research on health care, and to characterise the papers cited on clinical guidelines.Design The bibliographic details of the papers cited in 15 clinical guidelines, developed in and for the United Kingdom, were collated and analysed with applied bibliometric techniques.Results The median age of papers cited in clinical guidelines was eight years; most papers were published by authors living in either the United States (36%) or the United Kingdom (25%)-this is two and a half times more than expected as about 10% of all biomedical outputs are published in the United Kingdom; and clinical guidelines do not cite basic research papers.Conclusion Analysis of the evidence base of clinical guidelines may be one way of tracking the flow of knowledge from the laboratory to the clinic.Moreover, such analysis provides a useful, clinically relevant method for evaluating research outcomes and different strategies in research and development.